Blinded, Randomized Study of Gabapentin (Neurontin(R)) and Gabapentin Enacarbil (Horizant(TM)) in Restless Leg Syndrome

Trial Profile

Blinded, Randomized Study of Gabapentin (Neurontin(R)) and Gabapentin Enacarbil (Horizant(TM)) in Restless Leg Syndrome

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2016

At a glance

  • Drugs Gabapentin (Primary) ; Gabapentin enacarbil (Primary)
  • Indications Restless legs syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2016 Status changed from recruiting to discontinued.
    • 11 Apr 2016 Planned End Date changed from 1 Oct 2015 to 1 Dec 2016.
    • 11 Apr 2016 Planned primary completion date changed from 1 Oct 2015 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top